iData’s report on the global peripheral vascular stents market covers bare-metal stents (BMS), covered stents, and drug-eluting stents (DES). In 2018, the drug-eluting stent market suffered extreme consequences after studies demonstrating the late-mortality signal from paclitaxel use within the peripheries were released. Although the FDA released a statement approving the use of paclitaxel devices, many
Over the past few years, the peripheral vascular device market has seen substantial growth. Driven by forward-pressing research, increased awareness about treatment options, and an aging population in the United States, the total number of procedures performed and, therefore, the total number of devices used, has seen a strong and steady increase. One main disease
According to a new atherectomy market study by iData Research, over 190,000 atherectomy procedures are performed each year in the United States. Atherectomy is a procedure that consists of removing atherosclerotic plaque from diseased arteries and can be performed either on coronary or peripheral arteries. Atherectomy devices are used as the treatment of choice, as
According to the latest market analysis by iData Research, the U.S. atherectomy market is expected to remain as one of the biggest contributors to the growth of the peripheral vascular market. While often performed in conjunction with other procedures, such as angioplasties, atherectomy procedures have been experiencing double-digit growth rates for the past two years
According to the latest market analysis by iData Research, there are over 12,000 intravascular lithotripsy procedures performed in the United States every year. This number is expected to experience incredible growth and double in number by 2026. This growth can be attributed to two main factors: the creation of procedure codes by CMS, and successful
It reduces reinterventions, and maintains access for end-stage renal disease for patients that have to undergo dialysis. This is what the clinical information highlighted for Medtronic’s latest product in the drug-coated balloon market, the IN.PACT AV DCB. The IN.PACT AV DCB delivers a proven anti-proliferative drug paclitaxel. This delivery increases the flow of blood and
Register to receive a free Peripheral Vascular Devices Market Analysis, Size, and Trends Report synopsis and brochure. In a new partnership following a proof of concept study, Optina Diagnostics and the Montreal Heart Institute are working on developing a new biomarker for the detection of atherosclerosis. Atherosclerosis is a disease where plaque builds up on
Register to receive a free U.S. Market Report Suite for Peripheral Vascular Devices – MedSuite report synopsis and brochure Vascular Graft Solutions Ltd. announced that it has received CE Mark approval for the Frame FR, a new solution for the repair and stabilization of high flow and aneurysmal arteriovenous fistulas in hemodialysis patients. “We are excited to
Register to receive a free U.S. Market Report Suite for Peripheral Vascular Devices – MedSuite report synopsis and brochure On May 15, 2019, W.L. Gore & Associates, Inc. announced that they have been granted FDA approval for distribution for the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System. It is a unique Thoracic Endovascular Aortic Repair
Register to receive a free U.S. Market Report Suite for Peripheral Vascular Devices and Accessories – MedSuite report synopsis and brochure Physeon has recently announced positive clinical trial results from their second clinical trial with Veinplicity®. The results demonstrate that cannulation success rates were significantly higher with the device when used before tourniquet in patients that were
